CapsoVision (CV) Other Non-Current Assets (2024 - 2026)
CapsoVision (CV) posted Other Non-Current Assets of $41000.0 for Q4 2025, little changed sequentially from $41000.0 in Q3 2025, and little changed YoY from $41000.0 in Q4 2024.
CapsoVision (CV) Other Non-Current Assets (2024 - 2026) Analysis & Trends
CapsoVision has reported Other Non-Current Assets for 2 years, with the latest figure at $41000.0 in Q4 2025.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $41000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $41000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $41000.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $41000.0 in Q4 2025 per CV's latest filing, from $41000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $41000.0 in Q4 2024 and troughed at $41000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 215.10 Mn |
| 10 | CapsoVision | 299.87 Mn | 290.80 Mn | 1.87 Mn | 76,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 76,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |